OR WAIT 15 SECS
Cognizant’s Shared Investigator Platform (SIP) has integrated with Oracle Health Sciences. Cognizant and Oracle have combined the SIP solution and study startup offerings to address site challenges and aim to deliver value in the initialization of studies, collaboration, and management.
“Being able to stay connected, reduce administrative work, and stand-up clinical trials quickly is paramount, especially as the world faces the pandemic and must maneuver around social distancing guidelines,” said Srinivas Shankar, Global Head of Life Sciences, Cognizant. “Since 2016, Cognizant’s Shared Investigator Platform has over 130,000 users across 100 countries. This digital solution, in collaboration with Oracle, is helping bridge digital technology and life sciences.”
For more information, click here.